Airway clearance therapy is an essential component of care for individuals with chronic respiratory conditions that impair mucus clearance, such as cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. When mucus accumulates in the airways, it creates an environment conducive to infection, inflammation, and progressive lung damage. Patients may experience persistent cough, recurrent respiratory infections, reduced exercise tolerance, and shortness of breath. Effective airway clearance therapy improves ventilation, reduces infection risk, and helps maintain lung function over time. Assessment typically includes evaluation of lung function, sputum characteristics, and patient ability to perform clearance techniques.
Treatment strategies involve both manual and mechanical methods tailored to individual needs. Manual techniques include postural drainage, percussion, and breathing exercises, while mechanical methods encompass high-frequency chest wall oscillation, positive expiratory pressure devices, and oscillatory vests. Pulmonary rehabilitation programs often integrate airway clearance therapy with exercise and breathing training to enhance overall respiratory efficiency. Hydration, mucolytic agents, and inhaled medications may further facilitate mucus mobilization. Education and adherence support are critical, ensuring that patients and caregivers can perform techniques safely and consistently. Regular monitoring of symptoms, lung function, and infection markers allows clinicians to adjust therapy as needed. By implementing comprehensive airway clearance therapy, patients can reduce exacerbations, preserve lung capacity, and improve quality of life, making it a cornerstone in managing chronic airway diseases.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation